Your browser doesn't support javascript.
loading
MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia.
Wu, Bian; Slabicki, Mikolaj; Sellner, Leopold; Dietrich, Sascha; Liu, Xiyang; Jethwa, Alexander; Hüllein, Jennifer; Walther, Tatjana; Wagner, Lena; Huang, Zhiqin; Zapatka, Marc; Zenz, Thorsten.
Afiliación
  • Wu B; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Slabicki M; Molecular Therapy in Haematology and Oncology & Department of Translational Oncology, National Centre for Tumour Disease (NCT) and German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Sellner L; Molecular Therapy in Haematology and Oncology & Department of Translational Oncology, National Centre for Tumour Disease (NCT) and German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Dietrich S; Molecular Therapy in Haematology and Oncology & Department of Translational Oncology, National Centre for Tumour Disease (NCT) and German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Liu X; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Jethwa A; Molecular Therapy in Haematology and Oncology & Department of Translational Oncology, National Centre for Tumour Disease (NCT) and German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Hüllein J; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Walther T; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
  • Wagner L; Molecular Therapy in Haematology and Oncology & Department of Translational Oncology, National Centre for Tumour Disease (NCT) and German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Huang Z; Molecular Therapy in Haematology and Oncology & Department of Translational Oncology, National Centre for Tumour Disease (NCT) and German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Zapatka M; Molecular Therapy in Haematology and Oncology & Department of Translational Oncology, National Centre for Tumour Disease (NCT) and German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Zenz T; Molecular Therapy in Haematology and Oncology & Department of Translational Oncology, National Centre for Tumour Disease (NCT) and German Cancer Research Centre (DKFZ), Heidelberg, Germany.
Br J Haematol ; 179(3): 421-429, 2017 11.
Article en En | MEDLINE | ID: mdl-28771672
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Receptor Notch1 / Complejo Mediador / Mutación Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Br J Haematol Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Receptor Notch1 / Complejo Mediador / Mutación Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Br J Haematol Año: 2017 Tipo del documento: Article